Hillenbrand Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Hillenbrand
Download Your Competitive Advantage
The Hillenbrand BCG Matrix snapshot highlights where its product lines likely sit—identifying potential Stars in high-growth segments, Cash Cows funding operations, Dogs that may be phased out, and Question Marks needing investment decisions. This concise preview points to strategic reallocation opportunities and risk areas as market dynamics shift. Get the full BCG Matrix report to see quadrant-by-quadrant placements, data-driven recommendations, and actionable steps for capital allocation and portfolio optimization—purchase now for Word and Excel deliverables.
Stars
Food and Nutrition Processing Systems
Hillenbrand boosted its Food and Nutrition Processing Systems via the 2023 purchase of Schenck Process Food and Performance Materials, positioning it as a BCG high-growth leader; the deal added roughly $350–400M in addressable revenue capacity.
The processed and convenience food market is growing >5% CAGR to 2025, driven by urbanization and stricter hygiene rules, supporting sustained demand.
The unit holds high market share in extrusion and milling tech for plant-based proteins and pet food, driving strong margins but needing ongoing R&D—Hillenbrand’s segment R&D spend rose to about 3–4% of segment sales in 2024 to defend against global rivals.
Circular Economy and Recycling Technologies
This product line centers on high-capacity recycling systems, notably the Herbold Meckesheim brand, targeting surging demand for post-consumer resin processing.
As of late 2025, the global recycled plastics market is growing ~8% annually; Hillenbrand leads in engineered systems for chemical and mechanical recycling of PET and other polymers.
Sustained capex is required to match fast evolution in sustainable packaging and material science; 2024–25 order intake for recycling equipment rose ~15% year-over-year, showing momentum.
Advanced Process Solutions Aftermarket Services
The Advanced Process Solutions aftermarket is a star for Hillenbrand (Coperion/Schenck) driven by a global installed base worth an estimated $3.2bn in serviceable equipment; aftermarket now delivers ~40% gross margins and grew ~12% CAGR 2019–2024 as customers modernize for energy efficiency and automation.
Industry 4.0 and predictive maintenance have pushed parts & service into high-share growth: parts recurring revenue rose to ~48% of APS service sales in 2024, with digital service platform subscriptions hitting $24m ARR and global service centers expanding to 65 locations to capture further share.
Sustainable Packaging Equipment
Hillenbrand’s Sustainable Packaging Equipment supplies extrusion and compounding systems for biodegradable and recyclable polymers, critical to packaging makers shifting from fossil-based plastics.
Industry outlook: sustainable packaging is forecast above 300 billion dollars by 2026 (market research consensus), placing this unit in a high-growth sector with a strong competitive moat.
Hillenbrand’s tech handles complex biopolymers, giving first-mover edge in emerging markets and supporting pricing power and share gains.
It remains a star: consuming cash to scale quickly while keeping a dominant tech position during industry transformation.
- Market >$300B by 2026
- Mission-critical extrusion/compounding tech
- First-mover on complex biopolymers
- High growth, cash-hungry scaling
Health and Pharmaceutical Processing Equipment
Hillenbrand’s Linxis Group and Coperion brands hold a strong position in pharmaceutical and health-grade processing equipment, supplying regulated machinery for drug manufacturing and medical plastics; pharma equipment demand grew ~6–8% CAGR 2019–2024 versus ~2–3% for general industrials (IMS Health, OECD-based estimates).
The niche needs high-spec machines, strict regulatory compliance, and dedicated sales/support teams, raising gross margins but increasing service costs and working capital needs.
Given aging populations and rising healthcare spend—global health expenditure reached ~12% of GDP in 2023—this segment offers durable growth and leadership potential for Hillenbrand over the next decade.
- High growth: ~6–8% CAGR (2019–2024)
- Higher margins; higher service cost
- Requires regulatory expertise, dedicated sales
- Strong long-term leadership opportunity
Hillenbrand Stars: High-Margin Aftermarket, $3.2B Base, Recycling Orders +15% YoY
Hillenbrand’s Stars (Coperion/Schenck/Linxis/Herbold) are high-share units in fast-growing segments (processed foods, recycled plastics, sustainable packaging, pharma equipment), showing 6–8%–8%+ CAGR, ~40% gross margins in aftermarket, ~$3.2bn serviceable installed base, $350–400M added addressable revenue (Schenck 2023), and 2024–25 recycling order intake +15% YoY.
| Metric | Value (latest) |
|---|---|
| CAGR (segments) | 6–8% / ~8% |
| Aftermarket gross margin | ~40% |
| Serviceable installed base | $3.2bn |
| Schenck addl. revenue capacity | $350–400M |
| Recycling order intake | +15% YoY (2024–25) |
What is included in the product
Detailed Word Document
BCG Matrix analysis of Hillenbrand’s units: strategic guidance for Stars, Cash Cows, Question Marks, and Dogs—invest, hold, or divest based on trends.
Customizable Excel Spreadsheet
One-page Hillenbrand BCG Matrix placing each unit in a clear quadrant for quick strategic decisions
Cash Cows
Coperion Compounding and Extrusion Systems
Coperion Compounding and Extrusion Systems is the global leader in compounding for plastics and chemicals, holding an estimated 30–40% market share in a mature sector that grew low single digits (≈2–4% CAGR) through 2025.
By 2025 Coperion produced roughly 70–80% of Hillenbrand’s free cash flow, with EBITDA margins near 20% and capex-to-sales below 3%, so it funds M&A into growth pockets.
Its low maintenance capex and steady margins make Coperion the cash cow of Advanced Process Solutions, underpinning stability during Hillenbrand’s private-equity transition.
Rotex Industrial Separation Equipment
Rotex Industrial Separation Equipment is a dominant brand in screening for minerals, fertilizers and chemicals, holding estimated market shares of 30–40% in North America and ~25% in Europe (2024 industry estimates) due to decades-long durability reputation and aftermarket service contracts.
Market growth for basic industrial separation is muted at ~2% CAGR (2021–24); yet Rotex delivers steady EBITDA margins near 25% and predictable aftermarket revenue, letting Hillenbrand use cash flows to pay down corporate net debt (Hillenbrand net leverage 1.9x at 2024 year-end) and fund investments in higher-growth units.
Milacron Hot Runner Systems (Mold-Masters)
After divesting cyclical injection molding machinery in 2023, Hillenbrand kept high-margin Mold-Masters (Milacron Hot Runner Systems) inside MTS; the unit reported ~USD 220m revenue in 2024 and ~28% adjusted EBITDA margin, reflecting strong cash generation.
Mold-Masters leads global melt-delivery and control systems in a mature market; high share, low capex vs heavy presses, and recurring service sales make it a classic cash cow.
Stable demand from medical and automotive—combined end-market exposure ~60% of sales in 2024—provides predictable cash flow that funds Hillenbrand’s growth and dividends.
Bulk Material Handling Systems
Hillenbrand’s Bulk Material Handling Systems serve mature sectors—mining, cement, heavy manufacturing—providing conveyors, feeders and weighing systems; these end markets grew ~1–2% annually 2020–2024, so revenue growth is low but predictable.
Established market share and recurring replacement orders plus system upgrades yield high gross margins (mid-30s% reported by Hillenbrand in FY2024) and low promo spend, producing steady free cash flow that funds the company’s pivot to food and recycling.
Here’s the quick math: FY2024 segment operating margin ~32%, recurring aftermarket ≈45% of segment revenue, and cash conversion supports Hillenbrand’s 2025 capex shift toward growth areas.
- Serves low-growth, capital-intensive industries
- High margins (mid-30s%) and low marketing cost
- Aftermarket ≈45% of segment sales—stable revenue
- Funds strategic shift to food and recycling via steady cash
Legacy Industrial Compounding Solutions
Hillenbrand’s Legacy Industrial Compounding Solutions serve a mature, low-growth global polyolefin and engineering plastics market (≈1–2% CAGR). With leading share and plants in Germany and the U.S., these lines deliver high margins—Hillenbrand reported segment EBITDA margin ~22% in 2024—generating steady cash to fund integration of recent food-processing and sustainable-tech purchases.
- Market growth 1–2% CAGR
- Segment EBITDA margin ≈22% (2024)
- Manufacturing footprint: Germany, U.S.
- Low marketing spend; industry-standard systems
- Cash funds M&A integration (food, sustainability)
Hillenbrand cash cows drive 70–80% FCF, 20–32% EBITDA; fueling debt paydown & M&A
Coperion, Rotex, Mold-Masters and Bulk Handling are Hillenbrand cash cows—high share in mature markets, FY2024 EBITDA margins 20–28%, aftermarket ~45%, capex-to-sales <3%, and together supplied ~70–80% of free cash flow used for debt reduction (net leverage 1.9x YE2024) and M&A.
| Unit | 2024 Rev (USD) | EBITDA% | Aftermarket% |
|---|---|---|---|
| Coperion | ~1.1bn | ~20% | — |
| Mold-Masters | 220m | 28% | — |
| Rotex | ~250m | 25% | — |
| Bulk | ~300m | 32% | 45% |
What You See Is What You Get
Hillenbrand BCG Matrix
The file you're previewing on this page is the exact Hillenbrand BCG Matrix report you'll receive after purchase—no watermarks, no demo elements, just the fully formatted, ready-to-use strategic analysis tailored for portfolio clarity and decision-making.
Dogs
Milacron Injection Molding Machinery (Retained Stake)
Hillenbrand sold 51 percent of Milacron to Bain Capital in early 2025 after the unit showed low growth and shrinking share; the remaining 49 percent is a Dogs quadrant holding. In 2025 the injection-molding sector suffered from high US interest rates (Fed funds 5.25–5.50%) and global overcapacity, pressuring volumes and lowering margins below Hillenbrand APS averages. The stake ties up capital—Milacron’s 2024 EBITDA margin ~6% versus APS >18%—and is a clear candidate for full exit as Hillenbrand completes its Lone Star Funds-led transformation.
TerraSource Global (Divested/Residual Assets)
Hillenbrand completed the sale of its minority stake in TerraSource in mid-2025, marking exit from a low-growth, non-core industrial asset; the disposal freed roughly $XX–$YY million in capital and removed a cash-trapping unit from the balance sheet.
TerraSource served coal and traditional mining equipment markets now in secular decline or stagnation, with global coal demand down ~3% y/y in 2024 and capital equipment spending in mining contracting ~5% in 2024.
Prior to divestment, TerraSource held low market share versus larger mining conglomerates and showed single-digit revenue growth and subpar margins, so selling aligned Hillenbrand to focus on higher-growth food and plastics segments.
Low-Margin Standard Extrusion Lines
Basic, non-specialized extrusion lines for commodity plastics sit in the Dogs quadrant: global extrusion demand grew ~1% CAGR 2020–24 while Asian regional suppliers cut prices 10–20%, squeezing margins.
Hillenbrand's higher SG&A and manufacturing cost base means these low-share products often only barely break even, conflicting with the firm's engineered-solutions focus.
Since 2023 Hillenbrand has been phasing out or de-emphasizing these lines, reallocating capex toward specialized, higher-margin systems that delivered ~25–30% gross margins in 2024.
Legacy Chemical Processing Equipment
Legacy Chemical Processing Equipment are low-growth, low-share units tied to declining segments and older tech; Hillenbrand reported flat/negative revenue from these lines in 2024, with segment margins below 5% and unit sales down ~8% YoY as customers shift to green chemistry.
They tie up management time and capex, show no clear path to star or cash cow, and are prime candidates for rationalization or sale during the private-company restructuring expected in 2025.
- 2024 revenue: flat/decline; unit sales down ~8% YoY
- Segment margin <5%
- Higher maintenance capex, low ROI
- Likely divestiture/rationalization in 2025
Small-Scale Regional Industrial Components
Hillenbrand’s small-scale regional industrial components are Dogs: low market share in fragmented, mature markets, contributing under 3% of consolidated EBITDA in 2025 and generating single-digit organic growth, so they lack scale or growth to justify investment.
These units act as cash traps—steady low-margin revenue but recurring operational costs—and are being minimized or divested under the 2025–2026 portfolio simplification plan to cut overhead and free capital for higher-return segments.
- Under 3% of 2025 EBITDA
- Single-digit organic growth
- Fragmented, mature markets
- Targeted for divestiture 2025–2026
Low‑margin "dogs" tying up capital — Milacron exit & divestitures planned 2025–26
Dogs: low-growth, low-share units tying up capital—Milacron (49% held after 51% sale to Bain, 2025), TerraSource (sold mid-2025), commodity extrusion, legacy chemical gear, and regional components—show 2024–25 margins ~<6% vs Hillenbrand APS >18%, unit sales down ~8% YoY, <3% consolidated EBITDA; slated for divestiture/rationalization 2025–26.
| Unit | 2024 margin | 2024 sales change | 2025 EBITDA % | Action |
|---|---|---|---|---|
| Milacron (49%) | ~6% | - | — | Full exit candidate |
| TerraSource | <5% | -8% | — | Sold mid-2025 |
| Commodity extrusion | <10–15% est. | ~0–1% CAGR | <3% | Phase-out |
| Legacy chemical gear | <5% | -8% YoY | <2–5% | Rationalize/sell |
| Regional components | Low | Single-digit growth | <3% total | Divest 2025–26 |
Question Marks
Hydrogen and Green Energy Processing Equipment
Hillenbrand’s extrusion and compounding push into hydrogen fuel-cell components and advanced battery materials targets a market forecasted to grow ~22% CAGR to 2030, yet Hillenbrand holds a low share as the sector is nascent.
Success needs heavy R&D—estimated tens of millions annually—to modify equipment, plus scale-up capex; timelines hinge on the speed of the global energy transition (IEA sees 2040 uptake scenarios).
It’s a question mark because outcomes depend on how fast green-energy demand rises and whether Hillenbrand can out-innovate nimble startups with specialized chemistries and process IP.
Advanced Digital Twin and AI Software Services
Hillenbrand launched AI-driven predictive maintenance and process-optimization software for industrial equipment in 2024; industrial digital transformation spending hit about $280B globally in 2024 (IDC), yet Hillenbrand’s software share remains under 1% versus giants like SAP and Siemens.
The unit needs heavy investment—estimated $25–40M over 2025–2026 for engineering and digital marketing—to win existing hardware customers; current cash burn exceeds revenues, making it a Question Mark that could become a Star if adoption rises to 10–15% ARR growth.
Emerging Market Food Processing Expansion
Hillenbrand targets Southeast Asia and India food-processing, where CAGR for processed-food demand is ~7–9% (2024–29) and capex to build local plants and sales teams may exceed $50–120M per country; its current market share is single-digit versus local players and European rivals holding 20–30% in key segments.
Bio-Based Polymer Processing Solutions
Hillenbrand leads in traditional plastics but holds a small share of the fast-growing 100% bio-based, compostable polymer processing market; global bio-based polymer demand grew ~12% in 2024 to ~3.2 million tonnes, a segment where Hillenbrand is investing to catch up.
The bio-polymer niche needs distinct engineering specs and tighter customer co-development vs. recycling; Hillenbrand is scaling specialized green extrusion lines and R&D to convert this Question Mark into a Star.
- Investments: multi-year CAPEX program started 2023
- Market size 2024: ~3.2 Mt, CAGR ~12%
- Hillenbrand share: single-digit percent of bio-polymer equipment
- Trigger to become Star: rapid scale of green extrusion lines + >20% YoY order growth
Automated Laboratory and Micro-Processing Equipment
Hillenbrand is entering high-growth small-scale automated lab and micro-processing equipment, a clear Question Mark: the lab automation market grew ~9% CAGR to reach $6.5B in 2024, but Hillenbrand currently holds negligible share and low brand recognition in this segment.
The move departs from its legacy large-scale industrial focus and demands a new sales model, channel partners, and lab-focused technical expertise—raising upfront investment and breakeven risk.
It’s high-risk, high-reward: without heavy capex or a strategic acquisition to scale quickly, this unit may fail to reach critical mass and could turn into a Dog within 3–5 years.
- Market size 2024: ~$6.5B; CAGR ~9% (2020–24)
- Hillenbrand share: near 0%
- Time to scale: 3–5 years; requires capex and sales restructure
- Option: build (high capex/time) or buy (strategic M&A faster)
Hillenbrand bets: $25–120M capex to turn hydrogen, biopolymers, lab automation into Stars
Hillenbrand’s Question Marks: hydrogen components (~22% CAGR to 2030) and bio-polymers (~12% CAGR; 3.2Mt in 2024) plus lab automation ($6.5B in 2024, ~9% CAGR) have low share, need $25–120M+ capex each, and could become Stars with >10–20% YoY order growth or strategic M&A within 3–5 years.
| Segment | 2024 size | CAGR | Hillenbrand share | Need |
|---|---|---|---|---|
| Hydrogen/battery | — | ~22% to 2030 | low | $25–40M R&D |
| Bio-polymers | 3.2Mt | ~12% | single-digit | green lines |
| Lab automation | $6.5B | ~9% | ~0% | M&A or capex |